|
1
|
Ueno H, Shinto E, Shimazaki H, Kajiwara Y,
Sueyama T, Yamamoto J and Hase K: Histologic categorization of
desmoplastic reaction: Its relevance to the colorectal cancer
microenvironment and prognosis. Ann Surg Oncol. 22:1504–1512. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katz MH, Fleming JB, Bhosale P,
Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW,
Vauthey JN, et al: Response of borderline resectable pancreatic
cancer to neoadjuvant therapy is not reflected by radiographic
indicators. Cancer. 118:5749–5756. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ito Z, Takakura K, Suka M, Kanai T, Saito
R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, et al:
Prognostic impact of carbohydrate sulfotransferase 15 in patients
with pancreatic ductal adenocarcinoma. Oncol Lett. 13:4799–4805.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamamoto T, Matsuda Y, Kawahara K,
Ishiwata T and Naito Z: Secreted 70kDa lumican stimulates growth
and inhibits invasion of human pancreatic cancer. Cancer Lett.
320:31–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kai Y, Tomoda K, Yoneyama H, Kitabatake M,
Nakamura A, Ito T, Yoshikawa M and Kimura H: Silencing of
carbohydrate sulfotransferase 15 hinders murine pulmonary fibrosis
development. Mol Ther Nucleic Acids. 6:163–172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takakura K, Shibazaki Y, Yoneyama H, Fujii
M, Hashiguchi T, Ito Z, Kajihara M, Misawa T, Homma S, Ohkusa T and
Koido S: Inhibition of cell proliferation and growth of pancreatic
cancer by silencing of carbohydrate sulfotransferase 15 in vitro
and in a xenograft model. PLoS One. 10:e01429812015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugahara KN, Hirata T, Tanaka T, Ogino S,
Takeda M, Terasawa H, Shimada I, Tamura J, ten Dam GB, van
Kuppevelt TH and Miyasaka M: Chondroitin sulfate E fragments
enhance CD44 cleavage and CD44-dependent motility in tumor cells.
Cancer Res. 68:7191–7199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sato H, Sagara S, Nakajima N, Akimoto T,
Suzuki K, Yoneyama H, Terai S and Yahagi N: Prevention of
esophageal stricture after endoscopic submucosal dissection using
RNA-based silencing of carbohydrate sulfotransferase 15 in a
porcine model. Endoscopy. 49:491–497. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suzuki K, Arumugam S, Yokoyama J, Kawauchi
Y, Honda Y, Sato H, Aoyagi Y, Terai S, Okazaki K, Suzuki Y, et al:
Pivotal role of carbohydrate sulfotransferase 15 in fibrosis and
mucosal healing in mouse colitis. PLoS One. 11:e01589672016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watanabe K, Arumugam S, Sreedhar R,
Thandavarayan RA, Nakamura T, Nakamura M, Harima M, Yoneyama H and
Suzuki K: Small interfering RNA therapy against carbohydrate
sulfotransferase 15 inhibits cardiac remodeling in rats with
dilated cardiomyopathy. Cell Signal. 27:1517–1524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki K and Yoneyama H: New endoscopic
approach of anti-fibrotic therapy for inflammatory bowel disease.
Ann Transl Med. 5:1912017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suzuki K, Yokoyama J, Kawauchi Y, Honda Y,
Sato H, Aoyagi Y, Terai S, Okazaki K, Suzuki Y, Sameshima Y, et al:
Phase 1 clinical study of siRNA targeting carbohydrate
sulphotransferase 15 in crohn's disease patients with active
mucosal lesions. J Crohns Colitis. 11:221–228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hruban RH, Boffetta P, Hiraoka N,
Iacobuzio-Donahue C, Kato Y, Kern SE, et al: Tumours of the
pancreas. Bosman FT, Carneiro F, Hruban RH and Theise ND: WHO
Classification of Tumours of the Digestive System. 4th. IARC; Lyon:
2010
|
|
14
|
Nishimura M, Matsukawa M, Fujii Y, Matsuda
Y, Arai T, Ochiai Y, Itoi T and Yahagi N: Effects of EUS-guided
intratumoral injection of oligonucleotide STNM01 on tumor growth,
histology, and overall survival in patients with unresectable
pancreatic cancer. Gastrointest Endosc. 87:1126–1131. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyashita T, Tajima H, Makino I, Okazaki
M, Yamaguchi T, Ohbatake Y, Nakanuma S, Hayashi H, Takamura H,
Ninomiya I, et al: Neoadjuvant chemotherapy with gemcitabine plus
nab-paclitaxel reduces the number of cancer-associated fibroblasts
through depletion of pancreatic stroma. Anticancer Res. 38:337–343.
2018.PubMed/NCBI
|
|
16
|
Zhou ZC, Dong QG, Fu DL, Gong YY and Ni
QX: Characteristics of Notch2(+) pancreatic cancer stem-like cells
and the relationship with centroacinar cells. Cell Biol Int.
37:805–811. 2013. View Article : Google Scholar : PubMed/NCBI
|
